Arena Pharma (ARNA) Misses Q4 EPS by 28c
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Gain from valuation of derivative liabilities: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Gain from valuation of derivative liabilities: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q4 EPS of ($2.54), $0.28 worse than the analyst estimate of ($2.26). Revenue for the quarter came in at $54 thousand versus the consensus estimate of $660 thousand.
Cash, cash equivalents and marketable securities were $0.7 billion at December 31, 2021 as compared to $1.1 billion at December 31, 2020
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
